545 related articles for article (PubMed ID: 318094)
1. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
2. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
3. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
[TBL] [Abstract][Full Text] [Related]
4. Trophoblastic markers in women using intrauterine contraception.
Ylikorkala O; Siljander M; Huhtaniemi I; Kauppila A; Seppälä M
Obstet Gynecol; 1980 Mar; 55(3):329-32. PubMed ID: 6965779
[TBL] [Abstract][Full Text] [Related]
5. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
6. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
Klein TA; Mishell DR
Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
[TBL] [Abstract][Full Text] [Related]
7. The menstrual cycle in women using an intrauterine device.
Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
[TBL] [Abstract][Full Text] [Related]
8. Trophoblastic markers in the differential diagnosis of ectopic pregnancy.
Kauppila A; Rantakylä P; Huhtaniemi I; Ylikorkala O; Seppälä M
Obstet Gynecol; 1980 May; 55(5):560-4. PubMed ID: 6966042
[TBL] [Abstract][Full Text] [Related]
9. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
[TBL] [Abstract][Full Text] [Related]
11. Chorionic gonadotropin in women fitted with intrauterine device.
Yarkoni S; Zer TA; Schenker JG
Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
[TBL] [Abstract][Full Text] [Related]
12. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
[TBL] [Abstract][Full Text] [Related]
13. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) and human chorionic gonadotropin (beta-hCG) in women using an intrauterine device.
Tamsen L; Eneroth P
Contraception; 1986 May; 33(5):497-501. PubMed ID: 2428559
[TBL] [Abstract][Full Text] [Related]
15. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin in intrauterine device users.
Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
[TBL] [Abstract][Full Text] [Related]
17. Norplant implants: the mechanism of contraceptive action.
Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotrophin (hCG) in IUD users.
Dhont M; Thiery M; Vanlancker M
IRCS J Med Sci; 1984 Sep; 12(9):862. PubMed ID: 12340100
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin levels in lactating women using progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
[TBL] [Abstract][Full Text] [Related]
20. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
